MCID: HYP024
MIFTS: 53

Hypoparathyroidism malady

Categories: Rare diseases, Endocrine diseases

Aliases & Classifications for Hypoparathyroidism

About this section

Aliases & Descriptions for Hypoparathyroidism:

Name: Hypoparathyroidism 11 48 27 50 39 13 68
Hypoparathyroidism, Idiopathic 48
 
Parathyroid, Underactivity of 48

Classifications:



External Ids:

Disease Ontology11 DOID:11199
ICD1030 E20, E20.9, E20.0
ICD9CM32 252.1
MeSH39 D007011
NCIt45 C78350

Summaries for Hypoparathyroidism

About this section
NIH Rare Diseases:48 Hypoparathyroidism is is an endocrine disorder in which the parathyroid glands in the neck do not produce enough parathyroid hormone (pth). common signs and symptoms include abdominal pain, brittle nails, cataracts, dry hair and skin, muscle cramps, tetany, pain in the face, legs, and feet, seizures, tingling sensation, and weakened tooth enamel (in children). it may be caused by injury to the parathyroid glands (e.g., during surgery). other causes, include low blood magnesium levels, a side effect of radioactive iodine treatment for hyperthyroidism, metabolic alkalosis, digeorge syndrome, and type i polyglandular autoimmune syndrome. the goal of treatment is to restore the calcium and mineral balance in the body. last updated: 3/10/2011

MalaCards based summary: Hypoparathyroidism, also known as hypoparathyroidism, idiopathic, is related to pseudohypoparathyroidism, type ib and hypoparathyroidism-retardation-dysmorphism syndrome. An important gene associated with Hypoparathyroidism is GCM2 (Glial Cells Missing Homolog 2), and among its related pathways are Osteoblast Signaling and G alpha (s) signalling events. The drug ergocalciferol has been mentioned in the context of this disorder. Affiliated tissues include kidney, testes and thyroid, and related mouse phenotypes are craniofacial and respiratory system.

Disease Ontology:11 A parathyroid gland disease characterized by decreased function of parathyroid glands with underproduction of parathyroid hormone (PTH), leading to abnormally low ionized calcium levels in the blood.

Wikipedia:71 Hypoparathyroidism is decreased function of the parathyroid glands with underproduction of parathyroid... more...

Related Diseases for Hypoparathyroidism

About this section

Diseases in the Hypoparathyroidism family:

Secondary Hypoparathyroidism Due to Impaired Parathormon Secretion Autoimmune Hypoparathyroidism

Diseases related to Hypoparathyroidism via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 236)
idRelated DiseaseScoreTop Affiliating Genes
1pseudohypoparathyroidism, type ib29.9PRKAR1A, PTH
2hypoparathyroidism-retardation-dysmorphism syndrome12.3
3hypoparathyroidism, familial isolated12.3
4hypoparathyroidism, sensorineural deafness, and renal dysplasia12.2
5hypoparathyroidism-deafness-renal disease syndrome12.1
6hypoparathyroidism-intellectual disability-dysmorphism syndrome12.1
7autoimmune hypoparathyroidism12.0
8hypoparathyroidism, x-linked11.9
9secondary hypoparathyroidism due to impaired parathormon secretion11.8
10lymphedema-hypoparathyroidism syndrome11.7
11hypocalcemia, autosomal dominant11.7
12hypoparathyroidism short stature mental retardation11.7
13casr-associated familial isolated hypoparathyroidism11.7
14casr-related familial isolated hypoparathyroidism11.7
15gcm2-related familial isolated hypoparathyroidism11.7
16pth-related familial isolated hypoparathyroidism11.7
17autoimmune polyendocrinopathy syndrome , type i, with or without reversible metaphyseal dysplasia11.5
18autoimmune polyendocrine syndrome type 111.5
19pseudohypoparathyroidism11.4
20kearns-sayre syndrome11.1
21pseudohypoparathyroidism ic11.1
22pseudopseudohypoparathyroidism11.0
23dahlberg borer newcomer syndrome10.8
24kenny-caffey syndrome, type 110.7
25kenny-caffey syndrome, type 210.7
26velocardiofacial syndrome10.7
27ossification of the posterior longitudinal ligament of spine10.7
28macrocephaly/megalencephaly syndrome, autosomal recessive10.3GCM2, PTH
29bladder flat intraepithelial lesion10.3GATA3, PTH
30striatonigral degeneration10.3CASR, PTH
31mesenchymal cell neoplasm10.2CASR, PTH
32toxicodendron dermatitis10.2PTH, PTHLH
33lacrimal duct obstruction10.2GATA3, TBCE
34malignant granular cell myoblastoma10.2PTH, PTHLH
35prune belly syndome10.2GATA3, GCM2, PTH
36cerebrooculofacioskeletal syndrome 410.2CASR, PTHLH
37deafness, autosomal recessive 2910.2AIRE, CASR
38mixed germ cell cancer10.2PTH, PTHLH
39jessner's lymphocytic infiltration of the skin10.2CASR, PRKAR1A
40orbit lymphoma10.2FGF23, PTH
41epilepsy idiopathic generalized 810.2CASR, PRKAR1A
42nemaline myopathy 3, autosomal dominant or recessive10.2FAM111A, PTH, TBCE
43thyroiditis10.2
44renal dysplasia10.2
45familial chronic myelocytic leukemia-like syndrome10.1CASR, PTH, SPG7
46eiken syndrome10.1PTH, PTH1R
47uterine corpus endometrial stromal sarcoma10.1GATA3, PTHLH
48strabismus10.1GATA3, PTH, PTHLH
49joubert syndrome 910.1FGF23, PTH
50progressive locomotor ataxia10.1FGF23, PTHLH

Comorbidity relations with Hypoparathyroidism via Phenotypic Disease Network (PDN):


HyperparathyroidismAcute Cystitis
Chronic Kidney FailureDeficiency Anemia
Familial Atrial FibrillationHeart Disease
Hypertension, EssentialHypothyroidism
Postsurgical Hypothyroidism

Graphical network of the top 20 diseases related to Hypoparathyroidism:



Diseases related to hypoparathyroidism

Symptoms & Phenotypes for Hypoparathyroidism

About this section

MGI Mouse Phenotypes related to Hypoparathyroidism according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053829.0GATA3, GCM2, PRKAR1A, PTH, PTH1R, PTHLH
2MP:00053888.6AIRE, FGF23, PRKAR1A, PTH1R, PTHLH, TBCE
3MP:00053818.5AIRE, CASR, FGF23, GATA3, PRKAR1A, PTH1R
4MP:00053798.5AIRE, CASR, FGF23, GATA3, GCM2, PRKAR1A
5MP:00053767.9AIRE, CASR, FGF23, GATA3, GCM2, PRKAR1A
6MP:00053787.6AIRE, CASR, FGF23, GATA3, PRKAR1A, PTH
7MP:00107687.6AIRE, CASR, FGF23, GATA3, GCM2, PRKAR1A
8MP:00053906.8CASR, FGF23, GATA3, GCM2, PRKAR1A, PTH

Drugs & Therapeutics for Hypoparathyroidism

About this section

Drugs for Hypoparathyroidism (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 129)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Methylphenidateapproved, investigationalPhase 4375113-45-14158
Synonyms:
.alpha.-Phenyl-2-piperidineacetic acid methyl ester
113-45-1
2-Piperidineacetic acid, .alpha.-phenyl-, methyl ester
2-Piperidineacetic acid, alpha-phenyl-, methyl ester
298-59-9 (hydrochloride)
4311/B Ciba
AC1L1HJM
C 4311
C07196
CHEBI:6887
CHEMBL796
CID4158
Calocain
Centedein
Centedrin
Centedrine
Centredin
Concerta
D-Methylphenidate HCl
D04999
DB00422
DB06701
DEA No. 1724
Daytrana
Daytrana (TN)
EINECS 204-028-6
Focalin
Focalin XR
HSDB 3126
L001307
LS-565
METHYLPHENIDATE (SEE ALSO: METHYLPHENIDATE HYDROCHLORIDE, CAS 298-59-9, NTPNO 10266-R)
MPH
Meridil
Metadate
Metadate CD
Metadate ER
MethyPatch
Methyl (2-phenyl-2-(2-piperidyl)acetate)
Methyl alpha-phenyl-alpha-(2-piperidyl)acetate
Methyl alpha-phenyl-alpha-2-piperidinylacetate
Methyl phenidate
 
Methyl phenidyl acetate
Methyl phenidylacetate
Methylfenidan
Methylin
Methylin ER
Methylofenidan
Methylphen
Methylphenidan
Methylphenidate
Methylphenidate (USAN/INN)
Methylphenidate HCl
Methylphenidate [INN:BAN]
Methylphenidate hydrochloride
Methylphenidatum
Methylphenidatum [INN-Latin]
Methylphenidylacetate hydrochloride
Methypatch
Metilfenidat hydrochloride
Metilfenidato
Metilfenidato [INN-Spanish]
Metilfenidato [Italian]
MolPort-001-779-620
NCI-C56280
PMS-Methylphenidate
Phenidylate
Plimasine
Riphenidate
Ritalin
Ritalin LA
Ritalin SR
Ritalin hydrochloride
Ritalin-SR
Ritaline
Ritcher Works
Ritcher works
Tsentedrin
UNII-207ZZ9QZ49
alpha-Phenyl-2-piperidineacetic acid methyl ester
alpha-Phenyl-alpha-(2-piperidyl)acetic acid methyl ester
d-methylphenidate HCl
methyl 2-phenyl-2-piperidin-2-ylacetate
methyl phenyl(piperidin-2-yl)acetate
methylphenidate
nchembio.2007.55-comp28
2
DopamineapprovedPhase 4383651-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
3
Betamethasoneapproved, vet_approvedPhase 4195378-44-99782
Synonyms:
.beta.-Methasone
.beta.-Methasone alcohol
1,4-Pregnadiene-3,20-dione-9alpha-fluoro-16 beta-methyl-11 beta,17alpha,21-triol
16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione
16β-Methyl-1,4-pregnadiene-9α-fluoro-11β,17α,21-triol-3,20-dione
24024-03-1
34166_FLUKA
34166_RIEDEL
378-44-9
4-08-00-03501 (Beilstein Handbook Reference)
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione
9-Fluoro-16.beta.-methylprednisolone
9-Fluoro-16beta-methylprednisolone
9-Fluoro-16β-methylprednisolone
9-alpha-Fluoro-16-beta-methylprednisolone
9.alpha.-Fluoro-16.beta.-methylprednisolone
9alpha-Fluoro-16 beta-methyl-prednisolone
9alpha-Fluoro-16beta-methylprednisolone
9α-Fluoro-16β-methylprednisolone
AC1L1EYE
AC1L1TT4
AC1Q5HJZ
AKOS001582690
AR-1A7284
AR-1H5595
B1837
B7005_SIAL
B7005_SIGMA
B9675_SIAL
BIDD:PXR0047
BPBio1_000533
BRD-A35108200-001-04-7
BRD-K39188321-001-03-9
BRN 3176546
BSPBio_000483
Bebate
Becort
Bedifos
Betacorlan
Betacortril
Betadexamethasone
Betafluorene
Betamamallet
Betametasona
Betametasona [INN-Spanish]
Betametasone
Betametasone [DCIT]
Betamethasone
Betamethasone (JP15/USP/INN)
Betamethasone Base
Betamethasone Valearate
Betamethasone [USAN:BAN:INN:JAN]
Betamethasone [USAN:INN:BAN:JAN]
Betamethasone alcohol
Betamethasone cream
Betamethasonum
Betamethasonum [INN-Latin]
Betamethasonvalerat Mikron
Betamethazone
Betapredol
Betasolon
Betnelan
 
Betsolan
C22H29FO5
CHEBI:3077
CHEMBL632
CID3003
CID9782
CPD000339803
Celestene
Celeston
Celestona
Celestone
Celestone Syrup and Tablets
Celestone, Betadexamethasone, Flubenisolone, Sch-4831, NCS-39470, Betamethasone
Cellestoderm
Cidoten
D00244
D1961
DB00443
Desacort-Beta
EINECS 206-825-4
Flubenisolone
HMS1569I05
HSDB 3015
Hormezon
I06-0121
KST-1A3042
LS-118466
LT00441022
Luxiq
Luxiqo
MLS-0310139.0001
MLS000686794
MLS000859943
MLS001066413
MLS001332616
MLS002153244
Methazon
MolPort-003-845-025
MolPort-007-981-051
NCGC00164401-01
NCGC00164401-02
NSC 39470
NSC-39470
NSC39470
Prestwick0_000362
Prestwick1_000362
Prestwick2_000362
Prestwick3_000362
Prestwick_703
Rinderon
Rinderon (TN)
Rinderon A
S1500_Selleck
SAM002589959
SCH 4831
SCH-4831
SMP1_000043
SMR000058601
SMR000339803
SPBio_002404
UNII-9842X06Q6M
Valisone
Visubeta
ZINC03876136
beta-Methasone
beta-Methasone alcohol
betamethasone
4
Risperidoneapproved, investigationalPhase 4492106266-06-25073
Synonyms:
106266-06-2
3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one
3-(2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl)-2-methyl-6,7,8,9-tetrahydro-pyrido[
3-(2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl)-2-methyl-6,7,8,9-tetrahydropyrido[1,
3-[2-[-4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido [1,2-a] pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperi-dino]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,
3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
AB00514010
AC-1306
AC1L1JJU
BIDD:GT0262
BRD-K53857191-001-04-5
BRN 4891881
Belivon
Bio-0092
Buspirone
C23H27FN4O2
CAS-106266-06-2
CHEBI:8871
CHEMBL85
CID5073
CPD000466323
Consta, Risperdal
D00426
D018967
DB00734
EU-0101074
HMS1571M19
HMS2051H07
HMS2089C22
HSDB 7580
I01-1156
Jsp000573
KS-1106
L000510
LS-134196
Lopac-R-118
MLS000759429
MLS001165758
MLS001424081
MolPort-002-885-858
 
NCGC00015883-01
NCGC00015883-02
NCGC00015883-03
NCGC00094352-01
NCGC00094352-02
NCGC00094352-03
NCGC00179257-01
Prestwick0_001029
Prestwick1_001029
R 62 766
R 64 766, Risperdal, Risperidone
R 64,766
R 64766
R-118
R-64,766
R-64-766
R-64766
R64,766
R64766
Rispen
Risperdal
Risperdal (TN)
Risperdal Consta
Risperdal M-Tab
Risperidal
Risperidal M-Tab
Risperidona
Risperidona [Spanish]
Risperidone
Risperidone (JAN/USAN/INN)
Risperidone (RIS)
Risperidone [USAN:BAN:INN]
Risperidone, placebo
Risperidonum
Risperidonum [Latin]
Risperin
Rispolept
Rispolin
S1615_Selleck
SAM001246595
SMR000466323
SPBio_003078
STK646402
Sequinan
Spiron
TL8000230
UNII-L6UH7ZF8HC
risperdone
risperidone
5
Ergocalciferolapproved, nutraceuticalPhase 4, Phase 3128150-14-65280793
Synonyms:
'Ergosterol irradiated'
(+)-Vitamin D2
(3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol
(3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol
31316-19-5
4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol
47768_SUPELCO
50-14-6
7489-18-1
7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87
8017-28-5
9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol
9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol
95220_FLUKA
95220_SIGMA
AC-1355
AC1L1FIE
AC1NQXLH
AC1NS4DE
AC1NS9GI
AC1NSSVD
AC1NWAM3
AC1O5EDK
AC1O6WAM
ACon1_002187
Activated ergosterol
BPBio1_000418
BSPBio_000380
BSPBio_001974
Buco-D
C05441
C28H44O
CALCIFEROL IN A GELATIN MATRIX
CALCIFEROL, U.S.P.
CHEBI:28934
CHEMBL1536
CID11003810
CID3249
CID5280793
CID5315257
CID5353610
CID5356615
CID5702050
CID6432478
CID6536972
Calciferol
Calciferol (TN)
Calciferol (vitamin D2)
Calciferolum
Calciferon 2
Condacaps
Condocaps
Condol
Crtron
Crystallina
D-Arthin
D-Tracetten
D00187
DB00153
Daral
Davitamon D
Davitin
De-rat concentrate
Decaps
Dee-Osterol
Dee-Ron
Dee-Ronal
Dee-Roual
Deltalin
Deratol
Detalup
Diactol
Divit urto
Doral
Drisdol
Drisdol (TN)
E5750_SIGMA
EINECS 200-014-9
Ercalciol
Ergocalciferol
Ergocalciferol (D2)
Ergocalciferol (JP15/USP)
Ergocalciferol [INN:BAN:JAN]
Ergocalciferol oil
Ergocalciferol: Vitamin D
 
Ergocalciferolo
Ergocalciferolo [DCIT]
Ergocalciferols
Ergocalciferolum
Ergocalciferolum [INN-Latin]
Ergorone
Ergosterol activated
Ergosterol irradiated
Ergosterol, irradiated
Ertron
Fortodyl
Geltabs
Geltabs Vitamin D
HMS1920K20
HMS2091B19
HMS502I07
HSDB 819
Haliver
Hi-Deratol
Hyperkil
I05-0022
IDI1_000805
Infron
Irradiated ergosta-5,7,22-trien-3-beta-ol
Irradiated ergosta-5,7,22-trien-3.beta.-ol
Irradiated ergosta-5,7,22-trien-3beta-ol
Irradiated ergosterol
LMST03010001
LMST03010014
LS-3228
MEGxm0_000466
MLS001332467
MLS001332468
Metadee
Mina D2
MolPort-001-740-057
MolPort-001-793-930
MolPort-002-526-645
MolPort-003-666-178
MolPort-006-822-629
Mulsiferol
Mykostin
NCGC00142497-01
NCGC00179579-01
NCGC00179579-02
NSC 62792
NSC62792
Novovitamin-D
Oleovitamin D
Oleovitamin D, Synthetic
Oleovitamin D2
Osteil
Ostelin
Prestwick3_000420
Prestwick_554
Radiostol
Radstein
Radsterin
Rodine C
Rodinec
SMR000857106
SPECTRUM1500276
ST057150
STOCK1N-53397
Shock-ferol
Shock-ferol sterogyl
Sorex C.R
Sorex C.R.
Spectrum5_000666
Sterogyl
Synthetic Vitamin D
UNII-VS041H42XC
Uvesterol D
Uvesterol-D
VITAMIN D2
VITAMIN D2 WATER DISPERSABLE U.S.P.
VITAMIN_D2
Vigantol
Vio D
Vio-D
Viostdrol
Viosterol
Viosterol in Oil
Vitamin D2
Vitamin- D2
Vitamin-?D2
Vitamina D2
Vitavel-D
WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ
ZINC04474571
ZINC04629876
beta-Ol
bmse000510
component of Geltabs Vitamin D
delta-Arthin
delta-Tracetten
ergocalciferol
vitamin d-2
6
Cholecalciferolapproved, nutraceuticalPhase 4, Phase 387567-97-06221, 10883523, 5280795
Synonyms:
()-Vitamin D3
(+)-Vitamin D3
(+)-vitamin D3
(1S,3Z)-3-[(2e)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol
(3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3β,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(5E,7E)-9,10-Secocholesta-5,7,10-trien-3-ol
(5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-3-ol
(5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol
1406-16-2
25(OH)D
3-beta,Z,7E-9,10-Secocholestr-5,7,10(19)-trien-3-ol
47763_SUPELCO
57651-82-8
67-97-0
7-Dehydrocholesterol activated
7-Dehydrocholesterol, Activated
7-Dehydrocholesterol, irradiated
7-Dehydrocholestrol, activated
8024-19-9
8050-67-7
89193_FLUKA
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3-ol
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3beta-ol
9,10-Secocholesta-5(Z),7(E),10(19)-trien-3(.beta.)-ol
9,10-Secocholesta-5,7,10(19)-trien-3-beta-ol
9,10-Secocholesta-5,7,10(19)-trien-3-ol
9,10-Secocholesta-5,7,10-trien-3-ol
AB1002422
AC-11697
AC1L1ECK
AC1L1M23
AC1LU7IZ
AC1NQXLN
AC1NR2UO
AC1NR2UR
AC1NR2UU
AC1NS4AJ
AC1NSHJX
AC1O5EOF
AC1O7GAV
AC1O7GQ3
AC1O8FEU
AC1O8PWJ
AC1OF2GI
AC1OF2GL
AC1OIEW5
AC1OIEWB
ACon1_001997
Activated 7-dehydrocholesterol
Arachitol
BPBio1_000460
BSPBio_000418
BSPBio_002408
Bio-0845
C05443
C1357_SIAL
C27H44O
C9756_SIGMA
C9774_SIAL
CAS-67-97-0
CC
CCRIS 5813
CCRIS 6286
CHEBI:283119
CHEBI:28940
CHEMBL1042
CHEMBL432780
CID10000117
CID10045875
CID10340013
CID10883523
CID10894379
CID11014566
CID11025493
CID11058152
CID11463269
CID1548921
CID2735
CID5280795
CID5283710
CID5283711
CID5283712
CID5353527
CID5363362
CID6221
CID6432644
CID6604201
CID6604662
CID6708595
CID6713938
CID6992015
CID6992016
CID7067439
CID7067440
CID7251172
CID7251174
CID9821465
Calciol
Cholecalciferol
Cholecalciferol (D3)
Cholecalciferol (JP15/USP)
Cholecalciferol D3
Cholecalciferol [USAN:BAN:JAN]
Cholecalciferol, D3
Cholecalciferolum
Colecalciferol
 
Colecalciferol (INN)
Colecalciferolo
Colecalciferolo [DCIT]
Colecalciferolum
Colecalciferolum [INN-Latin]
Colecalcipherol
D00188
D3-Vicotrat
D3-Vigantol
DB00169
Delsterol
Delta-D
Delta-D (TN)
Deparal
Devaron
DivK1c_006276
Duphafral D3 1000
EINECS 200-673-2
EINECS 215-797-2
EPA Pesticide Chemical Code 202901
Ebivit
FeraCol
Granuvit D3
HMS1569E20
HMS2092M12
HSDB 820
I05-0041
Irradiated 7-dehydrocholesterol
KBio1_001220
KBio2_001643
KBio2_004211
KBio2_006779
KBio3_001628
KBioGR_001602
KBioSS_001643
LMST03020001
LMST03020219
LMST03020220
LMST03020221
LS-1570
LS-825
LT00244775
MEGxm0_000458
Micro-dee
MolPort-001-740-051
MolPort-001-785-972
MolPort-003-666-021
MolPort-004-946-964
NCGC00016301-01
NCGC00017328-01
NCGC00091072-01
NCGC00142511-01
NCGC00159331-02
NCGC00159331-04
NCGC00178668-01
NCGC00179565-01
NCGC00179565-02
NEO Dohyfral D3
NSC 375571
NSC-375571
NSC375571
Oleovitamin D3
Prestwick0_000429
Prestwick1_000429
Prestwick2_000429
Prestwick3_000429
Prestwick_63
Provitamine
Provitina
Quintox
Rampage
Ricketon
SMP1_000068
SPBio_001298
SPBio_002357
SR-05000001559
SR-05000001559-3
ST057172
SpecPlus_000180
Spectrum2_001369
Spectrum3_000764
Spectrum4_001201
Spectrum_001163
TNP00266
Trivitan
UNII-1C6V77QF41
UPCMLD-DP152
UPCMLD-DP152:001
VITAMIN D
VITAMIN D3 POWDER
VITAMIN_D3
Vi-De3
Vi-de-3-hydrosol
VidDe-3-hydrosol
Videkhol
Vigantol
Vigorsan
Vitamin D-3
Vitamin D3
Vitamin D3 emulsifiable
Vitinc Dan-Dee-3
ZINC04474460
ZINC04492874
ZINC04492875
ZINC04492876
ZINC04492878
bmse000507
cholecalciferol
colecalciferolum
vitamin d-3
7Hormone AntagonistsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 113180
8Bone Density Conservation AgentsPhase 4, Phase 2, Phase 3, Phase 13376
9HormonesPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 114415
10Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 113168
11MicronutrientsPhase 4, Phase 3, Phase 26001
12ErgocalciferolsPhase 4, Phase 31281
13Calcium, DietaryPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 15713
14vitamin dPhase 4, Phase 3, Phase 21724
15Trace ElementsPhase 4, Phase 3, Phase 26001
16VitaminsPhase 4, Phase 2, Phase 35282
17glucocorticoidsPhase 4, Phase 1, Phase 25103
18Anti-Inflammatory AgentsPhase 4, Phase 1, Phase 210729
19Neurotransmitter Uptake InhibitorsPhase 43521
20Neurotransmitter AgentsPhase 418340
21Betamethasone acetatePhase 48
22Psychotropic DrugsPhase 46430
23Betamethasone sodium phosphatePhase 4195
24
SerotoninPhase 4362750-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
25Tranquilizing AgentsPhase 44265
26Serotonin AntagonistsPhase 41409
27Serotonin AgentsPhase 43156
28Dopamine AntagonistsPhase 41093
29Dopamine Uptake InhibitorsPhase 41331
30Dopamine AgentsPhase 43836
31Betamethasone-17,21-dipropionatePhase 4195
32Betamethasone ValeratePhase 41952152-44-5
33Respiratory System AgentsPhase 44997
34Betamethasone benzoatePhase 4195
35Anti-Asthmatic AgentsPhase 43488
36Antipsychotic AgentsPhase 42401
37Central Nervous System StimulantsPhase 42211
38Central Nervous System DepressantsPhase 413403
39Vitamin D2NutraceuticalPhase 4, Phase 31281
40CalciferolNutraceuticalPhase 4, Phase 31383
41
Teriparatideapproved, investigationalPhase 2, Phase 313752232-67-416133850
Synonyms:
52232-67-4
D06078
Forteo
Forteo (TN)
 
TERIPARATIDE
Teriparatide (USAN/INN)
Teriparatide (genetical recombination)
Teriparatide (genetical recombination) (JAN)
Teriparatide recombinant human
42
Progesteroneapproved, vet_approvedPhase 355957-83-05994
Synonyms:
(S)-4-Pregnene-3,20-dione
(S)-Pregn-4-en-3,20-dione
(S)-Progesterone
.beta.-Progesterone
.delta.(sup4)-Pregnene-3,20-dione
.delta.4-Pregnene-3,20-dione
17.alpha.-Progesterone
17a-Progesterone
17alpha-Progesterone
17alpha-progesterone
17α-progesterone
1dbb
1h60
257630-50-5
3,20-Pregnene-4
32104FB6-BF81-4F6E-83C2-024DEEAEB272
4-Pregnen-3,20-dione
4-Pregnene-3,20-dione
46665_FLUKA
46665_RIEDEL
57-83-0
753497-20-0
8012-32-6
8023-13-0
AC-700
AC1L1LKF
AI3-51682
Agolutin
Akrolutin
BB_NC-0185
BHR-100
BIDD:ER0547
BIDD:PXR0094
BPBio1_000676
BRD-K64994968-001-03-6
BSPBio_000614
Bio-luton
C00410
CCRIS 533
CHEBI:17026
CHEMBL103
CID5994
CIDR
CMC_13406
COL-1620
CPD000058345
Colprosterone
Corlutin
Corlutina
Corluvite
Corporin
Corpus Luteum Hormone
Corpus luteum hormone
Crinone
Crinone (TN)
Crinone progesterone gel
Curretab
Cyclogest
Cyclogesterin
D00066
D4-Pregnene-3,20-dione
DB00396
DR-2011
Delalutin
Delta(4)-pregnene-3,20-dione
Duraprogen
EINECS 200-350-6
ETI-411
EU-0100895
Endometrin
Estima
FE-999913
Flavolutan
Fologenon
Gelbkoerperhormon
Gesterol
Gesterol 100
Gesterol 50
Gestiron
Gestone
Gestormone
Gestron
Glanducorpin
Gynlutin
Gynoluton
Gynolutone
HMS1569O16
HMS2051O05
HMS2090J07
HSDB 3389
Hormoflaveine
Hormoluton
Hydroxyprogesterone Caproate
Hydroxyprogesterone Caproic acid
LMST02030159
LS-234
Lingusorbs
Lipo-Lutin
Lipolutin
Lopac0_000895
Lucorteum
Lucorteum Sol
Lucorteum sol
Lugesteron
Luteal hormone
Luteinique
Luteocrin normale
Luteodyn
Luteogan
Luteohormone
Luteol
Luteol (VAN)
Luteopur
Luteosan
Luteostab
Luteovis
Luteum
Lutex
Lutidon
Lutin
Lutinus
Lutociclina
Lutocuclin M
Lutocyclin
Lutocyclin M
 
Lutocyclin m
Lutocylin
Lutocylol
Lutoform
Lutogyl
Lutogynon
Lutren
Lutromone
MLS000028517
MLS000758277
MLS001074187
MLS002222367
MPA
Membrettes
Methylpregnone
Micronized Progesterone
MolPort-001-794-643
NCGC00022185-03
NCGC00022185-04
NCGC00022185-05
NCGC00022185-06
NCGC00022185-07
NCGC00022185-08
NCGC00022185-09
NCGC00090798-01
NCGC00090798-02
NCI60_042166
NSC 64377
NSC 9704
NSC-9704
NSC64377
NSC9704
Nalutron
Natural Progesterone
P 0130
P0130_SIGMA
P0478
P3972_SIGMA
P6149_SIGMA
P7556_ALDRICH
P7556_SIGMA
P8783_SIGMA
P9776_SIGMA
PROGESTERONE
Percutacrine
Percutacrine Luteinique
Piaponon
Pranone
Pregn-4-en-3,20-dione
Pregn-4-ene-3,20-dione
Pregnene-3,20-dione
Pregnenedione
Prestwick0_000477
Prestwick1_000477
Prestwick2_000477
Prestwick3_000477
Prestwick_411
Primolut
Prochieve
Progeffik
Progekan
Progestan
Progestasert
Progesterol
Progesteron
Progesterona
Progesterona [INN-Spanish]
Progesterone
Progesterone (JP15/USP/INN)
Progesterone [INN:BAN:JAN]
Progesterone [Progestins]
Progesterone, water-soluble
Progesterone-Water Soluble
Progesterone: HBC complex
Progesteronum
Progesteronum [INN-Latin]
Progestin
Progestogel
Progestol
Progeston
Progestone
Progestosol
Progestrel
Progestron
Progestronol
Progestérone
Projestaject
Prolets
Prolidon
Prolutin
Proluton
Prolutone
Prometrium
Prometrium (TN)
Prontogest
Protormone
S00293
S1705_Selleck
SAM001247039
SMR000058345
SMR000653542
SPBio_002553
SR-01000000088
SR-01000000088-5
Spectrum5_002053
Syngesterone
Syngestrets
Synovex S
Syntolutan
U 3672
UNII-4G7DS2Q64Y
Utrogest
Utrogestan
Vitarrine
WLN: L E5 B666 OV MUTJ A1 E1 FV1
ZINC04428529
beta-Progesterone
bmse000482
component of Cyclogesterin
corpus luteum hormone
delta(4)-Pregnene-3,20-dione
delta(Sup 4)-Pregnene-3,20-dione
delta(Sup4)-pregnene-3,20-dione
delta(sup 4)-Pregnene-3,20-dione
delta4-Pregnene-3,20-dione
luteohormone
nchembio.2007.53-comp14
43
Vitamin Eapproved, nutraceutical, vet_approvedPhase 2, Phase 341459-02-914985
Synonyms:
(+)-a-Tocopherol
(+)-alpha-Tocopherol
(+)-α-tocopherol
(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL
(2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
(2R,4'R,8'R)-a-Tocopherol
(2R,4'R,8'R)-alpha-Tocopherol
(2R,4'R,8'R)-α-tocopherol
(R,R,R)-a-Tocopherol
(R,R,R)-alpha-Tocopherol
(R,R,R)-α-tocopherol
5,7,8-Trimethyltocol
5,7,8-trimethyltocol
Amino-Opti-E
Aquasol E
D-alpha-Tocopherol
Daltose
Denamone
E-200 I.U. Softgels
 
E-Complex-600
E-Ferol
E-Vitamin succinate
Eprolin
Gordo-Vite E
Phytogermin
Phytogermine
RRR-alpha-tocopherol
RRR-alpha-tocopheryl
Tocopherol
Vitamin E
Vitamin Ea
Vitamin Plus E Softgells
Vitec
a-D-Tocopherol
a-Tocopherol
alpha-Tocopherol
alpha-delta-Tocopherol
alpha-tocopherol
d-α-tocopherol
delta-alpha-Tocopherol
44TocotrienolsPhase 2, Phase 3410
45CoagulantsPhase 31500
46TocopherolsPhase 2, Phase 3414
47HemostaticsPhase 31443
4817-alpha-hydroxy-progesterone caproatePhase 332
4911-hydroxyprogesteronePhase 332
50ProgestinsPhase 3564

Interventional clinical trials:

(show top 50)    (show all 85)
idNameStatusNCT IDPhase
1Does Treatment of Hypovitaminosis D Increase Calcium Absorption?CompletedNCT00581828Phase 4
2Steroids in the Postoperative Transient Hypoparathyroidism Total ThyroidectomyRecruitingNCT02652884Phase 4
3Extended Use of Recombinant Human Parathyroid Hormone (rhPTH(1-84)) in HypoparathyroidismRecruitingNCT02910466Phase 4
4The Psychiatric and Cognitive Phenotypes in Velocardiofacial SyndromeRecruitingNCT00768820Phase 4
5Vitamin D Deficiency and Postoperative HypocalcemiaActive, not recruitingNCT01632514Phase 4
6ADD-ON Study to Existing Hypoparathyroidism StudiesUnknown statusNCT00856401Phase 3
7Medico-economic Evaluation Comparing the Use of Ultrasonic Scissors to the Conventional Techniques of Haemostasis in Thyroid Surgery by CervicotomyUnknown statusNCT01551914Phase 3
8Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome.Unknown statusNCT02070211Phase 2, Phase 3
9Use of NPSP558 in the Treatment of HypoparathyroidismCompletedNCT00732615Phase 3
10Study of Safety and Efficacy of a rhPTH[1-84] of Fixed Doses of 25 and 50 mcg in Adults With Hypoparathyroidism (RELAY)CompletedNCT01268098Phase 3
11A Study to Investigate the Safety and Tolerability of NPSP558, for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study in HungaryCompletedNCT01455181Phase 3
12Bone Properties in Hypoparathyroidism: Effects of PTHCompletedNCT00473265Phase 2, Phase 3
13A Open-label Study Investigating the Safety and Tolerability of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH [1-84]), for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study (RACE)Active, not recruitingNCT01297309Phase 3
14HEXT (Hypo EXTended): Effect of PTH on Skeleton in HypoparathyroidismActive, not recruitingNCT01199614Phase 3
15Effects of PTH Replacement on Bone in HypoparathyroidismActive, not recruitingNCT00395538Phase 3
16Randomized Controlled Trial of Neo-adjuvant Progesterone and Vitamin D3 in Women With Large Operable Breast Cancer and Locally Advanced Breast CancerActive, not recruitingNCT01608451Phase 3
17Treatment of Hypoparathyroidism With Subcutaneous PTH (1-84) Injections: Effects on Muscle Function and Quality of LifeCompletedNCT00730210Phase 2
18Treatment of Hypoparathyroidism With Synthetic Human Parathyroid Hormone 1-34CompletedNCT00001304Phase 2
19A Study Comparing Amorphous Calcium Carbonate (ACC) Versus Crystalline Calcium CCS) in Hypoparathyroidism PatientsCompletedNCT01815021Phase 1, Phase 2
20A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of HypoparathyroidismCompletedNCT02152228Phase 2
21Intra-operative Infra-red Fluorescent Imaging in Thyroid and Parathyroid SurgeryCompletedNCT02089542Phase 1, Phase 2
22A Study to Determine the Effects of NPSP795 on the Calcium-sensing Receptor in Subjects With Autosomal Dominant Hypocalcemia as Measured by PTH Levels and Blood Calcium ConcentrationsCompletedNCT02204579Phase 2
23Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Autosomal Dominant HypocalcemiaRecruitingNCT02824718Phase 2
24Thyroid Gland Removal With or Without Central Lymph Node Dissection in Treating Patients With Node Negative Thyroid CancerRecruitingNCT02138214Phase 2
25Immune Disorder HSCT ProtocolRecruitingNCT01821781Phase 2
26Phase I/II Thymus Transplantation With Immunosuppression #950Active, not recruitingNCT00579527Phase 1, Phase 2
27Thymus Transplantation Dose in DiGeorge #932Active, not recruitingNCT00576836Phase 2
28Thymus Transplantation in DiGeorge Syndrome #668Active, not recruitingNCT00576407Phase 2
29Teriparatide for Postsurgical HypoparathyroidismTerminatedNCT01171690Phase 2
30Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial SyndromeTerminatedNCT01127503Phase 2
31Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric ConditionsCompletedNCT02895906Phase 1
32Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Subjects With HypoparathyroidismRecruitingNCT02781844Phase 1
33Study of rhPTH(1-84) in Japanese Healthy Subjects Compared With Matched Caucasian Healthy Adult SubjectsRecruitingNCT03150108Phase 1
34EIS in Thyroid and Parathyroid SurgeryRecruitingNCT02901873Phase 1
35Parathyroid and Thymus Transplantation in DiGeorge #931Active, not recruitingNCT00566488Phase 1
36Thymus Transplantation With ImmunosuppressionActive, not recruitingNCT00579709Phase 1
37Serum-Free Thymus Transplantation in DiGeorge AnomalyTerminatedNCT00849888Phase 1
38Vitamin D Levels and Postoperative Hypocalcemia After Total ThyroidectomyUnknown statusNCT01039714
39Genetic Modifiers for 22q11.2 SyndromeUnknown statusNCT00916955
40Genetics and Psychopathology in the 22q11 Deletion SyndromeUnknown statusNCT00161109
41Immunologic Evaluation in Patients With DiGeorge Syndrome or Velocardiofacial SyndromeUnknown statusNCT00005102
42Hypoparathyroidism in DenmarkCompletedNCT01498341
43Postoperative Dose of Parathyroid Hormone as a Marker for the Occurrence of Hypoparathyroidism After Total ThyroidectomyCompletedNCT02924532
44Magnesium Treatment in HypoparathyroidismCompletedNCT00824226
45Comparing Pump With Subcutaneous Injection Delivery of PTH 1-34 in the Management of Chronic HypoparathyroidismCompletedNCT00743782Early Phase 1
46Perioperative Parathormone Measurement and Sodium Bicarbonate Infusion Test After Total ThyroidectomyCompletedNCT00793689
47Physiologic Regulation of FGF-23CompletedNCT00356512
48Study of the Relationship Between Calcium Levels and Intact Parathyroid Hormone (iPTH) in Adults With Repaired or Palliated Conotruncal Cardiac DefectsCompletedNCT00004361
49Outcomes of Different Thyroid Resections for Multinodular Non-toxic GoiterCompletedNCT00946894
50Determinants of Thyroid Surgery OutcomesCompletedNCT02813733

Search NIH Clinical Center for Hypoparathyroidism

Inferred drug relations via UMLS68/NDF-RT46:


Cochrane evidence based reviews: hypoparathyroidism

Genetic Tests for Hypoparathyroidism

About this section

Genetic tests related to Hypoparathyroidism:

id Genetic test Affiliating Genes
1 Hypoparathyroidism27

Anatomical Context for Hypoparathyroidism

About this section

MalaCards organs/tissues related to Hypoparathyroidism:

36
Kidney, Testes, Thyroid, Bone, Skin, Brain, Heart

Publications for Hypoparathyroidism

About this section

Articles related to Hypoparathyroidism:

(show top 50)    (show all 720)
idTitleAuthorsYear
1
A Novel De novo GATA-binding Protein 3 Mutation in a Patient with Hypoparathyroidism, Sensorineural Deafness, and Renal Dysplasia Syndrome. (28524840)
2017
2
The hypoparathyroidism-associated mutation in Drosophila Gcm compromises protein stability and glial cell formation. (28051179)
2017
3
Failure of fragmented parathyroid gland autotransplantation to prevent permanent hypoparathyroidism after total thyroidectomy. (28064342)
2017
4
A Case of Primary Hypoparathyroidism Presenting with Acute Kidney Injury Secondary to Rhabdomyolysis. (27034860)
2016
5
Hypoparathyroidism after total thyroidectomy: prospective evaluation and relation with early hypocalcemia. (27346692)
2016
6
Epileptic seizure, as the first symptom of hypoparathyroidism in children, does not require antiepileptic drugs. (27957632)
2016
7
An unusual case of hypercalcemia in a patient of concomitant hypoparathyroidism and celiac disease. (27252747)
2016
8
Postoperative Hypoparathyroidism and the Viability of the Parathyroid Glands During Thyroidectomy. (27515510)
2016
9
Management of Hypoparathyroidism: Present and Future. (26938200)
2016
10
Good's syndrome and hypoparathyroidism combined with hypocalcaemia, hypokalemia, hypomagnesemia, and hypophosphatemia-Case report. (26875773)
2016
11
Refractory Hypoparathyroidism in a Child with Celiac Disease. (26964284)
2016
12
Presence of Auto-reactive, MHC class-I restricted, Calcium Sensing Receptor (CaSR) specific CD8(+) T cells in Idiopathic Hypoparathyroidism. (27805845)
2016
13
Hip Pain and Gait Disturbance Associated with Idiopathic Hypoparathyroidism. (27190909)
2016
14
Autosomal Dominant Hypocalcemia (Hypoparathyroidism) Types 1 and 2. (27803672)
2016
15
Seizure and tetany secondary to hypomagnesaemic hypoparathyroidism induced by a proton-pump inhibitor. (27896379)
2016
16
Proton pump inhibitors and symptomatic hypomagnesemic hypoparathyroidism. (27206762)
2016
17
Idiopathic Hypoparathyroidism Mimicking Ankylosing Spondylitis: A Case Report. (27115113)
2016
18
Vertebral fractures and bone mineral density in patients with idiopathic hypoparathyroidism on long term follow-up. (27813708)
2016
19
Chronic Hypoparathyroidism Due to Partial Thyroidectomy with Intracranial Calcification. (27241548)
2016
20
Management of Hypoparathyroidism: Summary Statement and Guidelines. (26943719)
2016
21
Therapy of Hypoparathyroidism with PTH(1-84): a Prospective Six Year Investigation of Efficacy and Safety. (27144931)
2016
22
Extensive bilateral striopallidodentate calcinosis: a 50A years history of hypoparathyroidism presenting like a parkinsonian syndrome. (27485169)
2016
23
Identification of autoimmune polyendocrine syndrome type 1 in patients with isolated hypoparathyroidism. (27219120)
2016
24
The deceptive concept of hypoparathyroidism and recurrence after parathyroidectomy in dialysis patients: are we offering a Procrustean bed to some patients? (27982325)
2016
25
Bone imaging in hypoparathyroidism. (27577725)
2016
26
The risk of hypoparathyroidism after central compartment lymph node dissection in the surgical treatment of pT1, N0 thyroid papillary carcinoma. (27212170)
2016
27
Identification of an orally active small-molecule PTHR1 agonist for the treatment of hypoparathyroidism. (27857062)
2016
28
Long-term outcome of cataract surgery in patients with idiopathic hypoparathyroidism and its relationship with their calcemic status. (27465913)
2016
29
Short-Term PTH(1-34) Therapy in Children to Correct Severe Hypocalcemia and Hyperphosphatemia due to Hypoparathyroidism: Two Case Studies. (27957353)
2016
30
Clinical and mutational spectrum of hypoparathyroidism, deafness and renal dysplasia syndrome. (27387476)
2016
31
Hypoparathyroidism and pseudohypoparathyroidism: etiology, laboratory features and complications. (27901178)
2016
32
Parathyroid Hormone Replacement Therapy in Hypoparathyroidism: A Meta-Analysis. (27254756)
2016
33
Hypercalcemia due to Milk-Alkali Syndrome and Fracture-Induced Immobilization in an Adolescent Boy with Hypoparathyroidism. (27184240)
2016
34
The Epidemiology of Hypoparathyroidism in Italy: An 8-Year Register-Based Study. (28012105)
2016
35
Epidemiology and health related quality of life in hypoparathyroidism in Norway. (27186861)
2016
36
Fahr's Syndrome and Secondary Hypoparathyroidism. (27141572)
2016
37
Long-Term Follow-Up and Treatment of Postoperative Permanent Hypoparathyroidism in Patients with Medullary Thyroid Carcinoma: Differences in Complete and Partial Disease. (27813050)
2016
38
Treatment of severe life threatening hypocalcemia with recombinant human teriparatide in patients with postoperative hypoparathyroidism - a case series. (27387245)
2016
39
Adipose-derived stem cells: A novel source of parathyroid cells for treatment of hypoparathyroidism. (27372875)
2016
40
Hypoparathyroidism and pregnancy. (27172871)
2016
41
Allotransplantation of macroencapsulated parathyroid cells as a treatment of severe postsurgical hypoparathyroidism: case report. (26997532)
2016
42
Living-donor parathyroid allotransplantation for therapy-refractory postsurgical persistent hypoparathyroidism in a nontransplant recipient - three year results: a case report. (27488573)
2016
43
Case of extensive basal ganglia calcification-Rare finding of Idiopathic Hypoparathyroidism. (27728189)
2016
44
Computed tomography anomalies associated with isolated hypoparathyroidism. (27980765)
2016
45
Coexistence of cutaneous phosphaturic mesenchymal tumour and postoperative hypoparathyroidism. (27032881)
2016
46
Presentation of Hypoparathyroidism: Etiologies and Clinical Features. (26943721)
2016
47
Correlations Between Changes in Undercarboxylated Osteocalcin and Muscle Function in Hypoparathyroidism. (27942265)
2016
48
Hypoparathyroidism - a rare mimicker of amyotrophic lateral sclerosis. (27514792)
2016
49
Organic psychosis due to hypoparathyroidism in an older adult: a case report. (27828563)
2016
50
A case of brain calcifications in postsurgical hypoparathyroidism. (26968176)
2016

Variations for Hypoparathyroidism

About this section

Expression for genes affiliated with Hypoparathyroidism

About this section
Search GEO for disease gene expression data for Hypoparathyroidism.

Pathways for genes affiliated with Hypoparathyroidism

About this section

Pathways related to Hypoparathyroidism according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.3FGF23, PTH, PTH1R
29.2PTH, PTH1R, PTHLH
39.2PTH, PTH1R, PTHLH
48.7PRKAR1A, PTH, PTH1R, PTHLH

GO Terms for genes affiliated with Hypoparathyroidism

About this section

Biological processes related to Hypoparathyroidism according to GeneCards Suite gene sharing:

(show all 14)
idNameGO IDScoreTop Affiliating Genes
1parathyroid gland developmentGO:006001710.5GATA3, GCM2
2response to fibroblast growth factorGO:007177410.5CASR, PTH
3developmental growthGO:004858910.5GATA3, TBCE
4cellular phosphate ion homeostasisGO:003064310.4FGF23, GCM2
5cAMP metabolic processGO:004605810.4PTH, PTHLH
6cellular response to vitamin DGO:007130510.4CASR, FGF23
7negative regulation of chondrocyte differentiationGO:003233110.3PTH, PTHLH
8bone resorptionGO:004545310.3PTH, PTH1R
9cell maturationGO:004846910.3GATA3, PTH1R
10positive regulation of inositol phosphate biosynthetic processGO:006073210.3PTH, PTH1R
11osteoblast developmentGO:000207610.1PTH1R, PTHLH
12adenylate cyclase-activating G-protein coupled receptor signaling pathwayGO:00071899.9PTH, PTH1R, PTHLH
13cellular calcium ion homeostasisGO:00068749.7CASR, GCM2, PTH, PTH1R
14skeletal system developmentGO:00015019.2PTH, PTH1R, PTHLH

Molecular functions related to Hypoparathyroidism according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1peptide hormone receptor bindingGO:00514289.8PTH, PTHLH

Sources for Hypoparathyroidism

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet